The Prognosis of Patients Tested Positive for Stenotrophomonas maltophilia from Different Sources

References

• Tong ZW, Li XF, Qiu J, et al. Stenotrophomonas maltophilia clinical distribution and drug resistance analysis (in Chinese). Chin J Microecol. 2012;24(8):741–743.
   Google Scholar
• Lin Y, Wang B, Zhang N, et al. Metagenomic Analysis Identified Stenotrophomonas maltophilia Pneumonia in an Infant Suffering From Unexplained Very Severe Pneumonia. Front Pediatr. 2019;7:380.
   PubMed Web of Science ®Google Scholar
• Hu FP, Guo Y, Zhu DM, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2021(in Chinese). Chin J of Infect Chemother. 2022;22(05):521–530.
   Google Scholar
• Prates M, Fernandes F, Proenca F, et al. Oral infection caused by Stenotrophomonas maltophilia: a rare presentation of an emerging opportunistic pathogen. Case Rep Infect Dis. 2020;2020:6346120.
   PubMed Web of Science ®Google Scholar
• Inviati A, Pellegrino DM, Schifano D. Severe hepatic abscess: conservative treatment of multi-organ infection by Stenotrophomonas maltophilia. A case report. Ann Med Surg. 2018;34:62–65.
   PubMed Web of Science ®Google Scholar
• Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.
   PubMed Web of Science ®Google Scholar
• Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893.
   PubMed Web of Science ®Google Scholar
• Abda EM, Krysciak D, Krohn-Molt I, et al. Phenotypic heterogeneity affects Stenotrophomonas maltophilia K279a colony morphotypes and beta-Lactamase expression. Front Microbiol. 2015;6:1373.
   PubMed Web of Science ®Google Scholar
• Blanchard AC, Waters VJ. Opportunistic pathogens in cystic fibrosis: epidemiology and pathogenesis of lung infection. J Pediatric Infect Dis Soc. 2022;11(Supplement_2):S3–S12.
   PubMedGoogle Scholar
• Olubunmi O, Adeolu O, Oreoluwa O, et al. Stenotrophomonas maltophilia infection in a patient with acute exacerbation of chronic obstructive pulmonary disease (COPD): a colonizer or true Infection? Am J Case Rep. 2020;21:e924577.
   PubMed Web of Science ®Google Scholar
• Nagaia C, Selene B, Felice V, et al. In vitro synergism of colistin and n-acetylcysteine against Stenotrophomonas maltophilia. Antibiotics. 2019;8(3):101.
   Google Scholar
• Baidya A, Kodan P, Fazal F, et al. Stenotrophomonas maltophilia: more than just a colonizer! Indian j Critical Care Med. 2019;23(9):434–436.
   PubMed Web of Science ®Google Scholar
• Hu LF, Gao LP, Ye Y, et al. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations. J Chemother. 2014;26(5):282–286.
   PubMed Web of Science ®Google Scholar
• Abbott IJ, Slavin MA, Turnidge JD, et al. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther. 2011;9(4):471–488.
   PubMed Web of Science ®Google Scholar
• Oyardi O, Savage PB, Erturan Z, et al. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis. J Antimicrob Chemother. 2021;76(2):443–450.
   PubMed Web of Science ®Google Scholar
• Li-Fen H, Xiao C, Ying Y, et al. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents. 2011;37(3):230–234.
   PubMed Web of Science ®Google Scholar
• Cruz-Córdova A, Mancilla-Rojano J, Luna-Pineda VM, et al. Molecular epidemiology, antibiotic resistance, and virulence traits of Stenotrophomonas maltophilia strains associated with an outbreak in a Mexican tertiary care hospital. Front Cell Infect Microbiol. 2020;10:50.
   PubMed Web of Science ®Google Scholar
• Jian J, Xie Z, Chen L. Risk factors for mortality in hospitalized patients with Stenotrophomonas maltophilia bacteremia. Infect Drug Resist. 2022;15:3881–3886.
   PubMed Web of Science ®Google Scholar
• Hafiz TA, Aldawood E, Albloshi A, et al. Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and Clinical Outcomes: understanding of the Recent Three Years’ Trends. Microorganisms. 2022;10(12):2506.
   PubMed Web of Science ®Google Scholar
• Sarzynski SH, Warner S, Sun J, et al. Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: a Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals. Open Forum Infect Di. 2022;9(2):ofab644.
   PubMed Web of Science ®Google Scholar
• Mizusawa M, Konuma T, Kato S, et al. Clinical outcomes of persistent colonization with multidrug-resistant Gram-negative rods in adult patients undergoing single cord blood transplantation. Int J Hematol. 2020;111(6):858–868.
   PubMed Web of Science ®Google Scholar
• Clinical and laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Third Informational Supplement, M100-S33. Wayne, PA: Clinical and Laboratory Standards Institute; 2023.
   Google Scholar
• Zhou H, Li GH, Zhuo C, et al. Diagnosis, treatment, prevention and control of Stenotrophomonas Maltophilia infection in China: expert Consensus. National Med J China. 2013;16:1203–1213.
   Google Scholar
• Cai B, Tillotson G, Benjumea D, et al. The burden of bloodstream infections due to Stenotrophomonas Maltophilia in the United States: a Large, retrospective database study. Open Forum Infect Dis. 2020;7(5):a141.
   Web of Science ®Google Scholar
• Elpis H, Annalisa O, Pavel D, et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry. J Cyst Fibros. 2020;19(3):376–383.
   PubMed Web of Science ®Google Scholar
• Guerci P, Bellut H, Mokhtari M, et al. Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study. Crit Care. 2019;23(1):371.
   PubMed Web of Science ®Google Scholar
• Zöllner SK, Kampmeier S, Froböse NJ, et al. Stenotrophomonas maltophilia Infections in Pediatric Patients - Experience at a European Center for Pediatric Hematology and Oncology. Front Oncol. 2021;11:752037.
   PubMed Web of Science ®Google Scholar
• Márió G, Edit U. Epidemiological trends and resistance associated with Stenotrophomonas maltophilia bacteremia: a 10-year retrospective cohort study in a tertiary-care hospital in Hungary. Diseases. 2019;7(2):41.
   PubMedGoogle Scholar
• Shi L, Wu AH, Cao L, et al. Risk factors for healthcare-associated infection of Stenotrophomonas maltophilia in intensive care unit(in Chinese). Chin J Infect Control. 2019;18(05):403–409.
   Google Scholar
• Wang YL, Scipione MR, Dubrovskaya Y, et al. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother. 2014;58(1):176–182.
   PubMed Web of Science ®Google Scholar
• Kanchanasuwan S, Rongmuang J, Siripaitoon P, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia. J Clin Med. 2022;11(11):65.
   Web of Science ®Google Scholar
• Yue C, Shen W, Hu L, et al. Effects of tigecycline combined with azithromycin against biofilms of multidrug-resistant Stenotrophomonas maltophilia isolates from a patient in China. Infect Drug Resist. 2021;14:775–786.
   PubMed Web of Science ®Google Scholar
• Bilen NM, Sahbudak BZ, Guner OG, et al. Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections. Pediatr Infect Dis J. 2023;42(5):374–380.
   PubMed Web of Science ®Google Scholar
• Gayretli AZ, Tanir G, Bayhan GI, et al. Risk Factors of Stenotrophomonas maltophilia Blood Stream Infections: comparison With Other Gram-Negative Blood Stream Infections in Children. Pediatr Infect Dis J. 2020;39(12):e406–e409.
   PubMed Web of Science ®Google Scholar
• Furuichi M, Ito K, Miyairi I. Characteristics of Stenotrophomonas maltophilia bacteremia in children. Pediatr Int. 2016;58(2):113–118.
   PubMed Web of Science ®Google Scholar
• Stewardson AJ, Marimuthu K, Sengupta S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19(6):601–610.
   PubMed Web of Science ®Google Scholar
• Yokota PK, Marra AR, Belucci TR, et al. Outcomes and Predictive Factors Associated with Adequacy of Antimicrobial Therapy in Patients with Central Line-Associated Bloodstream Infection. Front Public Health. 2016;4:284.
   PubMed Web of Science ®Google Scholar
• Adegoke AA, Stenström TA, Okoh AI. Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: looking Beyond Contemporary Antibiotic Therapy. Front Microbiol. 2017;8:2276.
   PubMed Web of Science ®Google Scholar